TCL Archive Study Finds Hormonal Therapy Reduces Risk Of Disease Progression In Prostate Cancer July 27, 2001
TCL Archive Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting June 20, 1986
TCL Archive White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns. September 30, 2005
